Gerald Woods is an Oncology physician affiliated with Children's Mercy Hospital. OpenAlex indexes 76 publications with 4,602 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 Gillham Rd
Kansas City, MO 641084619
Telephone
816-234-3265Registry record last updated 20 May 2014.
Clinical trials
- Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Global Blood Therapeutics, Inc.Program year20223 payments
- Global Blood Therapeutics, Inc.Program year20214 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 1987–1994 per NIH RePORTER. The latest:
- PROPHYLACTIC PENICILLIN IN SICKLE CELL DISEASE
Children'S Mercy Hosp (kansas City, Mo)
FY1994N01HB077044 - PROPHYLACTIC PENICILLIN IN SICKLE CELL DISEASE
Children'S Mercy Hosp (kansas City, Mo)
FY1993N01HB077044 - PROPHYLACTIC PENICILLIN IN SICKLE CELL DISEASE
Children'S Mercy Hosp (kansas City, Mo)
FY1992N01HB077044
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years
Pediatric Blood & Cancer
2022 - Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
New England Journal of Medicine
2014
Similar KOLs
Other experts from the same institution or the same specialty.
Bradley Warady, MD
Children's Mercy Hospital
Jay Portnoy, MD
Children's Mercy Hospital
Alan Gamis, MD
Children's Mercy Hospital
Douglas Blowey, MD
Children's Mercy Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”